| Primary |
| Upper Respiratory Tract Inflammation |
21.2% |
| Bronchitis |
8.0% |
| Nasopharyngitis |
8.0% |
| Gastritis |
6.2% |
| Cellulitis |
5.3% |
| Cerebral Infarction |
5.3% |
| Hypertension |
5.3% |
| Pharyngitis |
5.3% |
| Product Used For Unknown Indication |
5.3% |
| Pyelonephritis |
5.3% |
| Purulence |
4.4% |
| Pyrexia |
4.4% |
| Infection Prophylaxis |
3.5% |
| Antipyresis |
1.8% |
| Diabetes Mellitus |
1.8% |
| Hyperlipidaemia |
1.8% |
| Post Gastric Surgery Syndrome |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Urinary Tract Infection |
1.8% |
| Urticaria |
1.8% |
|
| Oculomucocutaneous Syndrome |
14.8% |
| Toxic Epidermal Necrolysis |
14.8% |
| Liver Disorder |
11.1% |
| Rhabdomyolysis |
11.1% |
| Drug Eruption |
7.4% |
| Interstitial Lung Disease |
7.4% |
| Renal Failure Acute |
7.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.7% |
| Erythema Multiforme |
3.7% |
| Muscle Spasms |
3.7% |
| Oral Mucosal Erythema |
3.7% |
| Rash |
3.7% |
| Stomatitis |
3.7% |
| Toxic Skin Eruption |
3.7% |
|
| Secondary |
| Upper Respiratory Tract Inflammation |
15.6% |
| Hypertension |
9.8% |
| Bronchitis |
8.8% |
| Cerebral Infarction |
6.3% |
| Tonsillitis |
6.3% |
| Gastritis |
5.4% |
| Encephalitis |
4.9% |
| Nasopharyngitis |
4.9% |
| Product Used For Unknown Indication |
4.9% |
| Rheumatoid Arthritis |
4.4% |
| Urinary Tract Infection |
4.4% |
| Pyelonephritis |
3.9% |
| Diabetes Mellitus |
3.4% |
| Drug Use For Unknown Indication |
2.9% |
| Glomerulonephritis Rapidly Progressive |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Pharyngitis |
2.4% |
| Antipyresis |
2.0% |
| Constipation |
2.0% |
| Post Gastric Surgery Syndrome |
2.0% |
|
| Interstitial Lung Disease |
16.7% |
| Oculomucocutaneous Syndrome |
11.1% |
| Liver Disorder |
8.3% |
| Pigmentation Disorder |
8.3% |
| Renal Failure Acute |
8.3% |
| Gastric Ulcer |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Abnormal Behaviour |
2.8% |
| Atrioventricular Block Second Degree |
2.8% |
| Cough |
2.8% |
| Dermatitis Allergic |
2.8% |
| Dialysis |
2.8% |
| Drug Eruption |
2.8% |
| Drug Ineffective |
2.8% |
| Erythema Multiforme |
2.8% |
| Liver Injury |
2.8% |
| Pyrexia |
2.8% |
| Rhabdomyolysis |
2.8% |
| Sepsis |
2.8% |
| Stomatitis |
2.8% |
|
| Concomitant |
| Prophylaxis |
14.0% |
| Hypertension |
8.8% |
| Decreased Appetite |
8.2% |
| Anxiety |
7.7% |
| Abdominal Pain |
6.8% |
| Gastric Ulcer |
6.2% |
| Oedema |
5.1% |
| Acute Sinusitis |
4.3% |
| Pruritus |
4.0% |
| Hepatic Neoplasm Malignant |
3.8% |
| Hepatitis |
3.8% |
| Constipation |
3.6% |
| Nausea |
3.4% |
| Computerised Tomogram |
3.2% |
| Analgesic Therapy |
3.1% |
| Asthma |
3.1% |
| Diabetes Mellitus |
3.0% |
| Rheumatoid Arthritis |
2.8% |
| Bronchitis |
2.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.6% |
|
| Interstitial Lung Disease |
14.5% |
| Diarrhoea |
8.4% |
| White Blood Cell Count Decreased |
8.4% |
| Abnormal Behaviour |
6.0% |
| Myopathy |
6.0% |
| Wrong Technique In Drug Usage Process |
6.0% |
| Left Ventricular Dysfunction |
4.8% |
| Pneumonia |
4.8% |
| Vascular Purpura |
4.8% |
| Vein Discolouration |
4.8% |
| Arteriosclerosis Obliterans |
3.6% |
| Liver Disorder |
3.6% |
| Neuromyopathy |
3.6% |
| Stevens-johnson Syndrome |
3.6% |
| Subdural Haematoma |
3.6% |
| Urticaria |
3.6% |
| Abscess |
2.4% |
| Angina Pectoris |
2.4% |
| Cholecystitis |
2.4% |
| Gait Disturbance |
2.4% |
|
